StreetInsider.com News Articles

Form 8-K NKGen Biotech, Inc. For: Jan 30

Thu, 05 Feb 2026 17:25:00 -0500

si-local-file:///var/storage/secattach/20260205/25956310.html

Form 8-K NKGen Biotech, Inc. For: Jan 30

Thu, 05 Feb 2026 17:25:00 -0500

si-local-file:///var/storage/secattach/20260205/25956310.html

Form 8-K NKGen Biotech, Inc. For: Jan 20

Mon, 26 Jan 2026 17:25:00 -0500

si-local-file:///var/storage/secattach/20260126/25894362.html

Form 8-K NKGen Biotech, Inc. For: Jan 20

Mon, 26 Jan 2026 17:25:00 -0500

si-local-file:///var/storage/secattach/20260126/25894362.html

NKGen Biotech appoints dementia expert Bruce Miller to advisory board

Thu, 22 Jan 2026 08:05:10 -0500

NKGen Biotech Inc. (OTC: NKGN) announced the appointment of Bruce L. Miller, M.D. to its Scientific Advisory Board. Miller serves as the A.W. and Mary Margaret Clausen Distinguished Professor in Neurology at the University of California, San Francisco, where he directs the Edward and Pearl Fein Memory and Aging Center and founded the Global Brain Health Institute.

The clinical-stage biotechnology company focuses on developing natural killer cell therapeutics. Miller brings expertise in Alzheimer's disease, frontotemporal dementia, and other neurocognitive disorders to the Santa Ana, California-based company.

Miller has published more than 2,000 peer-reviewed articles and authored books including "The Behavioral Neurology of

NKGen Biotech appoints dementia expert Bruce Miller to advisory board

Thu, 22 Jan 2026 08:05:10 -0500

Miller has published more than 2,000 peer-reviewed articles and authored books including "The Behavioral Neurology of

NKGen Biotech appoints dementia expert Bruce Miller to advisory board

Thu, 22 Jan 2026 08:05:10 -0500

Miller has published more than 2,000 peer-reviewed articles and authored books including "The Behavioral Neurology of

NKGen Biotech appoints dementia expert Bruce Miller to advisory board

Thu, 22 Jan 2026 08:05:10 -0500

Miller has published more than 2,000 peer-reviewed articles and authored books including "The Behavioral Neurology of

NKGen Biotech appoints dementia expert Bruce Miller to advisory board

Thu, 22 Jan 2026 08:05:10 -0500

Miller has published more than 2,000 peer-reviewed articles and authored books including "The Behavioral Neurology of

NKGen Biotech appoints dementia expert Bruce Miller to advisory board

Thu, 22 Jan 2026 08:05:10 -0500

Miller has published more than 2,000 peer-reviewed articles and authored books including "The Behavioral Neurology of

NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board

Thu, 22 Jan 2026 08:05:00 -0500

SANTA ANA, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the appointment of Bruce L. Miller, M.D. to its Scientific Advisory Board. Dr. Miller is internationally recognized for his leadership in Alzheimer’s disease (“AD”), frontotemporal dementia (“FTD”), and other neurocognitive disorders, and brings extensive scientific and clinical expertise to the Company.